<DOC>
	<DOC>NCT00468260</DOC>
	<brief_summary>To evaluate the effects of patupilone on the pharmacokinetics of warfarin in patients with advanced malignancies.</brief_summary>
	<brief_title>The Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Epothilone B</mesh_term>
	<mesh_term>Epothilones</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Inclusion criteria Participation in study EPO906A2120E1 Age ≥ 18 years of age Life expectancy ≥ 3 months Histologically documented advanced solid tumors which have progressed after standard systemic therapy or for which standard systemic therapy does not exist Completed all PK sampling in the core study Exclusion criteria Known diagnosis of human immunodeficiency virus (HIV) infection, hepatitis Female patients who are pregnant or breast feeding Patients with a severe and/or uncontrolled medical disease Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Cancer</keyword>
	<keyword>EPO906</keyword>
	<keyword>Patupilone</keyword>
</DOC>